|
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway |
|
|
|
Title: |
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway |
Author: |
Giurdanella, Giovanni Anfuso, Carmelina Daniela Olivieri, Melania Lupo, Gabriella Caporarello, Nunzia Eandi, Chiara M. Drago, Filippo Bucolo, Claudio Salomone, Salvatore |
Appeared in: |
Biochemical pharmacology |
Paging: |
Volume 96 (2015) nr. 3 pages 10 p. |
Year: |
2015 |
Contents: |
|
Publisher: |
Elsevier Inc. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|